CPHI (China Pharma Holdings, Inc.) רווח נקי למניה אחת בשנים עשר החודשים האחרונים

China Pharma Holdings (CPHI) faces pressure from VBP price regulations and environmental controls in the PRC. The TTM EPS dynamics demonstrate earnings resilience, where 71.20 represents the current level of the metric. Business efficiency is supported by external manufacturing outsourcing and marketing, while the localization of raw material chains with regional distributors ensures stable supplies of psychotropic drugs.
China Pharma Holdings, Inc. - פילוחים אנליטיים ומדדי מפתח (CPHI)

This indicator measures the dynamics of net earnings per share over the last 12 months relative to the previous year. It serves as a stress-testing tool, separating real financial returns from market expectations. By analyzing the 12-month YoY EPS growth chart, an investor identifies trend reversal points in profitability. The stability of this metric for China Pharma Holdings (CPHI) is supported by a chemical raw material supply outsourcing strategy. A diversified pool of partners minimizes operational risks, ensuring profit sustainability.